Topic

Illinois

A collection of 429 issues

How to Get Rezlidhia (Olutasidenib) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Rezlidhia (Olutasidenib) Covered by Aetna CVS Health in Illinois Rezlidhia (olutasidenib) requires prior authorization from Aetna CVS Health. Your hematologist/oncologist must document IDH1 mutation, relapsed/refractory AML diagnosis, and prior treatment failures. If denied, you have 180 days to appeal internally, then 4 months for Illinois
5 min read

How to Get Rezlidhia (olutasidenib) Covered by UnitedHealthcare in Illinois: Appeals, Forms, and Approval Timeline

Answer Box: Getting Rezlidhia Covered in Illinois UnitedHealthcare requires prior authorization for Rezlidhia (olutasidenib) with documented IDH1 mutation and relapsed/refractory AML. Fastest path: Submit PA with IDH1 test results, prior therapy documentation, and oncologist's medical necessity letter via UnitedHealthcare provider portal. If denied, file internal appeal within
5 min read